Details for New Drug Application (NDA): 209914
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 209914
Tradename: | CLINDAMYCIN PHOSPHATE |
Applicant: | Encube Ethicals |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Pharmacology for NDA: 209914
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 209914
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 209914 | ANDA | Encube Ethicals Private Limited | 21922-002 | 21922-002-01 | 1 BOTTLE in 1 CARTON (21922-002-01) / 60 mL in 1 BOTTLE |
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 209914 | ANDA | Encube Ethicals Private Limited | 21922-002 | 21922-002-21 | 1 BOTTLE in 1 CARTON (21922-002-21) / 30 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | EQ 1% BASE | ||||
Approval Date: | Jan 28, 2019 | TE: | AT | RLD: | No |
Complete Access Available with Subscription